Improved chemotherapy before stem cell transplant for lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests a modified chemotherapy conditioning regimen (called improved BEAM) before your own stem cell transplant for non-Hodgkin lymphoma. The goal is to see if the new regimen is safer and works as well as the standard approach, possibly with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with non-Hodgkin lymphoma and plan to have your own stem cells transplanted after high-dose chemo.
- You are in good physical shape (able to care for yourself and be up and about more than half of the day).
- Your liver, kidneys, and heart are working well enough to handle the treatment.
- You have not had certain heart-related chemotherapy drugs before, or the total dose was within safe limits.
- You do not have active hepatitis B or C, HIV, or another cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study compares two chemotherapy schedules (Chi-BEAM vs BEAM) given before an autologous stem cell transplant to treat newly diagnosed peripheral T-cell lymphoma that responded to first-line treatment. If you fit the lab and heart/lung requirements, it may offer access to a new treatment approach designed to improve outcomes.
This trial tests whether adding the immunotherapy drug pembrolizumab (Keytruda) to the standard BEAM chemotherapy before a stem cell transplant can help people with relapsed Hodgkin lymphoma. It's for patients who are eligible for a transplant and have stable organ function.
This study tests a combination of four chemotherapy drugs given before a stem cell transplant to help prepare the body and reduce the chance of lymphoma returning. It is for people with certain types of lymphoma who are scheduled for this transplant.
This trial tests a stronger chemo and radiation plan before a stem cell transplant for people with myelodysplastic syndrome (a blood disorder) or acute myeloid leukemia (a blood cancer). The goal is to help the transplant work better and reduce the chance of the disease coming back.
This trial tests adding the drug selinexor to a standard high-dose chemotherapy regimen (BEAM) before an autologous stem cell transplant for people with MYC-positive diffuse large B-cell lymphoma that has returned or not responded to prior treatments. The goal is to see if this combination is safe and effective in preparing the body for the transplant.
This study tests a stronger pre-transplant conditioning regimen—using a liposome form of mitoxantrone with standard chemotherapy—to help wipe out remaining AML cells before a stem cell transplant. It is for people with higher-risk AML or who still have measurable disease before transplant.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.